Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors
- 1 February 2020
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 188, 112035
Abstract
No abstract availableKeywords
Funding Information
- Research Foundation
- Erciyes University (FYL-2019-9164)
- Erciyes University
This publication has 34 references indexed in Scilit:
- Crystal structure refinement withSHELXLActa Crystallographica Section C Structural Chemistry, 2015
- Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of TuberculosisJournal of Medicinal Chemistry, 2014
- One-pot four-component synthesis of 4-hydrazinothiazoles: novel scaffolds for drug discoveryTetrahedron Letters, 2014
- WinGXandORTEP for Windows: an updateJournal of Applied Crystallography, 2012
- New fluorine-containing hydrazones active against MDR-tuberculosisEuropean Journal of Medicinal Chemistry, 2011
- Mercury CSD 2.0– new features for the visualization and investigation of crystal structuresJournal of Applied Crystallography, 2008
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Pyrrolidine Carboxamides as a Novel Class of Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium tuberculosisJournal of Medicinal Chemistry, 2006
- Advances in the synthesis and recent therapeutic applications of 1,2,4-thiadiazole heterocyclesBioorganic & Medicinal Chemistry, 2006
- LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening FiltersJournal of Chemical Information and Modeling, 2004